Raia Drogasil S.A. (OTCMKTS:RADLY) Short Interest Update

Raia Drogasil S.A. (OTCMKTS:RADLY) was the target of a significant decline in short interest during the month of July. As of July 31st, there was short interest totaling 25,098 shares, a decline of 93.8% from the July 15th total of 402,126 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 15,813 shares, the short-interest ratio is presently 1.6 days.

Raia Drogasil Stock Down 6.8%

Shares of RADLY stock opened at $3.56 on Wednesday. Raia Drogasil has a 52-week low of $3.01 and a 52-week high of $5.34. The firm’s 50 day moving average price is $3.57 and its two-hundred day moving average price is $4.20.

Raia Drogasil (OTCMKTS:RADLY) last issued its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, meeting the consensus estimate of $0.05. The business had revenue of $2.17 billion for the quarter, compared to the consensus estimate of $2.32 billion. As a group, sell-side analysts expect that Raia Drogasil will post 0.17 earnings per share for the current fiscal year.

About Raia Drogasil

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.